Virtus Investment Advisers, Inc. Eagle Pharmaceuticals, Inc. Transaction History

Virtus Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$15.21 - $22.88 $15,179 - $22,834	-998 Reduced 4.56%	20,867 $329,000
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $258,241 - $463,931	14,557 Added 199.19%	21,865 $425,000
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $3,608 - $4,908	-144 Reduced 1.93%	7,308 $207,000
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $196,881 - $351,138	7,452 New	7,452 $197,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.